Works matching IS 18661947 AND DT 2022 AND VI 14

Results: 64
    1

    Long-term follow-up of a randomized controlled trial of choline for neurodevelopment in fetal alcohol spectrum disorder: corpus callosum white matter microstructure and neurocognitive outcomes.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09470-w
    By:
    • Gimbel, Blake A.;
    • Anthony, Mary E.;
    • Ernst, Abigail M.;
    • Roediger, Donovan J.;
    • de Water, Erik;
    • Eckerle, Judith K.;
    • Boys, Christopher J.;
    • Radke, Joshua P.;
    • Mueller, Bryon A.;
    • Fuglestad, Anita J.;
    • Zeisel, Steven H.;
    • Georgieff, Michael K.;
    • Wozniak, Jeffrey R.
    Publication type:
    Article
    2
    3
    4

    A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09466-6
    By:
    • Berry-Kravis, Elizabeth;
    • Hagerman, Randi;
    • Budimirovic, Dejan;
    • Erickson, Craig;
    • Heussler, Helen;
    • Tartaglia, Nicole;
    • Cohen, Jonathan;
    • Tassone, Flora;
    • Dobbins, Thomas;
    • Merikle, Elizabeth;
    • Sebree, Terri;
    • Tich, Nancy;
    • Palumbo, Joseph M.;
    • O'Quinn, Stephen
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09432-2
    By:
    • Buchanan, Caroline B.;
    • Stallworth, Jennifer L.;
    • Joy, Aubin E.;
    • Dixon, Rebekah E.;
    • Scott, Alexandra E.;
    • Beisang, Arthur A.;
    • Benke, Timothy A.;
    • Glaze, Daniel G.;
    • Haas, Richard H.;
    • Heydemann, Peter T.;
    • Jones, Mary D.;
    • Lane, Jane B.;
    • Lieberman, David N.;
    • Marsh, Eric D.;
    • Neul, Jeffrey L.;
    • Peters, Sarika U.;
    • Ryther, Robin C.;
    • Skinner, Steve A.;
    • Standridge, Shannon M.;
    • Kaufmann, Walter E.
    Publication type:
    Article
    32

    Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09446-w
    By:
    • Santoro, Jonathan D.;
    • Partridge, Rebecca;
    • Tanna, Runi;
    • Pagarkar, Dania;
    • Khoshnood, Mellad;
    • Rehmani, Mustafa;
    • Kammeyer, Ryan M.;
    • Gombolay, Grace Y.;
    • Fisher, Kristen;
    • Conravey, Allison;
    • El-Dahr, Jane;
    • Christy, Alison L.;
    • Patel, Lina;
    • Manning, Melanie A.;
    • Van Mater, Heather;
    • Rafii, Michael S.;
    • Quinn, Eileen A.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40

    Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers.

    Published in:
    Journal of Neurodevelopmental Disorders, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s11689-022-09434-0
    By:
    • Kothari, Cartik;
    • Srivastava, Siddharth;
    • Kousa, Youssef;
    • Izem, Rima;
    • Gierdalski, Marcin;
    • Kim, Dongkyu;
    • Good, Amy;
    • Dies, Kira A.;
    • Geisel, Gregory;
    • Morizono, Hiroki;
    • Gallo, Vittorio;
    • Pomeroy, Scott L.;
    • Garden, Gwenn A.;
    • Guay-Woodford, Lisa;
    • Sahin, Mustafa;
    • Avillach, Paul
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50